Matsuda Masaru
Insider CIK 1798679 · HALO SVP, General Counsel · ARQT See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-09-16 | 2026-09-18 | 3,674 | $25.00 | $91.8K | 112,508 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-09-16 | 2026-09-18 | 3,674 | $25.00 | $91.9K | 112,508 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-09-08 | 2026-09-10 | 9,989 | $25.03 | $250.0K | 116,182 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-09-08 | 2026-09-10 | 9,989 | $25.03 | $250.0K | 116,182 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-08-03 | 2026-08-05 | 1,230 | $26.12 | $32.1K | 126,171 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-08-03 | 2026-08-05 | 1,230 | $26.12 | $32.1K | 126,171 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-05-04 | 2026-05-06 | 884 | $23.61 | $20.9K | 126,689 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-05-04 | 2026-05-06 | 7,372 | $23.27 | $171.5K | 127,573 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-03-02 | 2026-03-03 | 193 | $25.91 | $5.0K | 136,932 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-03-02 | 2026-03-03 | 6,553 | $25.16 | $164.9K | 137,125 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-03-02 | 2026-03-03 | 1,987 | $25.70 | $51.1K | 136,932 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2026-02-27 | 2026-03-03 | 97,000 | — | $0 | 97,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2026-02-27 | 2026-03-03 | 37,000 | — | $0 | 147,003 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-02-27 | 2026-03-03 | 3,325 | $27.95 | $92.9K | 143,678 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-02-02 | 2026-02-04 | 8,562 | $24.97 | $213.8K | 134,096 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-02-02 | 2026-02-04 | 19,379 | $25.24 | $489.1K | 114,717 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-02-02 | 2026-02-04 | 4,714 | $25.63 | $120.8K | 110,003 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2026-02-02 | 2026-02-04 | 7,983 | $25.50 | $203.6K | 142,658 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-12-01 | 2025-12-03 | 1,657 | $30.23 | $50.1K | 150,641 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-11-19 | 2025-11-21 | 1,561 | $28.50 | $44.5K | 151,476 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-11-19 | 2025-11-21 | 989 | $27.95 | $27.6K | 153,037 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-11-03 | 2025-11-05 | 43 | $25.40 | $1.1K | 154,026 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-11-03 | 2025-11-05 | 7,165 | $24.71 | $177.0K | 154,069 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-09-04 | 2025-09-08 | 36,130 | $16.16 | $583.9K | 161,234 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-08-04 | 2025-08-05 | 6,330 | $14.33 | $90.7K | 197,364 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-05-28 | 2025-05-29 | 1,800 | $13.78 | $24.8K | 202,599 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-05-02 | 2025-05-05 | 5,030 | $15.20 | $76.5K | 204,399 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-03-03 | 2025-03-04 | 3,263 | $13.03 | $42.5K | 209,429 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2025-02-28 | 2025-03-04 | 89,000 | — | $0 | 89,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2025-02-28 | 2025-03-04 | 34,000 | — | $0 | 212,692 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-02-03 | 2025-02-04 | 8,338 | $12.70 | $105.9K | 178,692 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2024-11-30 | 2024-12-03 | 1,657 | $7.11 | $11.8K | 187,030 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-11-19 | 2024-11-19 | 1,775 | $9.68 | $17.2K | 181,373 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-11-18 | 2024-11-19 | 4,875 | — | $0 | 183,148 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-11-04 | 2024-11-05 | 5,015 | $8.68 | $43.5K | 178,273 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-08-02 | 2024-08-05 | 5,220 | $9.02 | $47.1K | 183,288 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2024-05-31 | 2024-12-03 | 4,000 | $1.69 | $6.8K | 185,373 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-05-28 | 2024-05-29 | 1,775 | $9.01 | $16.0K | 188,508 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-05-27 | 2024-05-29 | 4,875 | — | $0 | 190,283 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-05-02 | 2024-05-03 | 5,016 | $8.74 | $43.8K | 185,408 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-03-04 | 2024-03-06 | 3,760 | $11.12 | $41.8K | 190,424 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | D To issuer deriv | 2024-02-13 | 2024-02-15 | 35,300 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | D To issuer deriv | 2024-02-13 | 2024-02-15 | 55,800 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | D To issuer deriv | 2024-02-13 | 2024-02-15 | 185,000 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-02-13 | 2024-02-15 | 27,900 | — | $0 | 194,184 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-02-13 | 2024-02-15 | 17,650 | — | $0 | 166,284 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-02-13 | 2024-02-15 | 74,000 | — | $0 | 148,634 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2024-01-12 | 2024-01-17 | 176,000 | — | $0 | 176,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-01-12 | 2024-01-17 | 28,000 | — | $0 | 74,634 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2023-11-21 | 2023-11-21 | 1,850 | $1.98 | $3.7K | 46,634 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-11-18 | 2023-11-21 | 4,875 | — | $0 | 48,484 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-05-31 | 2023-06-02 | 1,463 | $6.38 | $9.3K | 43,609 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2023-05-31 | 2023-06-02 | 1,830 | $7.80 | $14.3K | 42,146 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-05-27 | 2023-06-02 | 4,875 | — | $0 | 43,976 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2023-03-02 | 2023-03-06 | 55,800 | — | $0 | 55,800 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2023-03-02 | 2023-03-06 | 18 | $16.52 | $297 | 18,101 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2023-03-02 | 2023-03-06 | 1,416 | $15.82 | $22.4K | 18,119 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2023-03-02 | 2023-03-06 | 21,000 | — | $0 | 39,101 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-11-21 | 2022-11-22 | 1,720 | $18.19 | $31.3K | 19,535 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2022-11-18 | 2022-11-22 | 4,875 | — | $0 | 21,255 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-06-02 | 2022-06-02 | 1,795 | $19.73 | $35.4K | 16,380 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2022-05-27 | 2022-06-02 | 4,875 | — | $0 | 18,175 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2022-03-03 | 2022-03-07 | 35,300 | — | $0 | 35,300 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2022-03-03 | 2022-03-07 | 13,300 | — | $0 | 13,300 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2022-01-03 | 2022-01-05 | 185,000 | — | $0 | 185,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2021-09-04 | 2021-09-07 | 6,883 | — | $0 | 6,883 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2021-09-04 | 2021-09-07 | 3,412 | $42.22 | $144.1K | 20,049 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2021-09-04 | 2021-09-07 | 6,883 | — | $0 | 23,461 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2021-02-15 | 2021-02-17 | 13,544 | — | $0 | 13,544 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2021-02-15 | 2021-02-17 | 23,311 | — | $0 | 23,311 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2021-02-12 | 2021-02-12 | 4,129 | — | $0 | 8,258 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2021-02-12 | 2021-02-12 | 2,047 | $49.84 | $102.0K | 16,578 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2021-02-12 | 2021-02-12 | 4,129 | — | $0 | 18,625 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2021-02-10 | 2021-02-12 | 6,257 | — | $0 | 18,769 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2021-02-10 | 2021-02-12 | 6,257 | — | $0 | 17,699 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2021-02-10 | 2021-02-12 | 3,203 | $50.60 | $162.1K | 14,496 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2020-09-04 | 2020-09-04 | 6,884 | — | $0 | 13,766 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2020-09-04 | 2020-09-04 | 6,884 | — | $0 | 13,822 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2020-09-04 | 2020-09-04 | 2,380 | $27.70 | $65.9K | 11,442 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise deriv | 2020-02-12 | 2020-02-13 | 4,130 | — | $0 | 12,387 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | F Tax w/h | 2020-02-12 | 2020-02-13 | 1,681 | $20.00 | $33.6K | 6,938 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | M Exercise | 2020-02-12 | 2020-02-13 | 4,130 | — | $0 | 8,619 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2020-02-10 | 2020-02-12 | 53,211 | — | $0 | 53,211 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2020-02-10 | 2020-02-12 | 25,026 | — | $0 | 25,026 | SEC↗ |